about
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope.The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations.Free radicals and antioxidants in cardiovascular diseases.The role of adiposity as a determinant of an inflammatory milieu.Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease?Role of new antiplatelet agents as adjunctive therapies in thrombolysis.Potential usefulness of combined thromboxane A2 and serotonin receptor blockade for preventing the conversion from chronic to acute coronary artery disease syndromes.Platelet biology and receptor pathways.Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice.Inflammation and cardiovascular disease: from pathogenesis to therapeutic target.Preoperative evaluation before MitraClip®: present and future perspective.Role of Tissue Factor in the Coagulation Network.Digoxin-induced vasoconstriction of normal and atherosclerotic epicardial coronary arteries.Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor.C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture.Evaluation of the antioxidant response in the plasma of healthy or hypertensive subjects after short-term exercise.Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.When chewing gum is more than just a bad habit.Myocardial strain analysis in a doxorubicin-induced cardiomyopathy model.Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts.Activated platelets stimulate tissue factor expression in smooth muscle cells.Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients?The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study.Increased heterogenity of ventricular repolarization in obese nonhypertensive children.Mickey Mouse in the cath lab.Activating stimuli induce platelet microRNA modulation and proteome reorganisation.Local cytokine production in patients with Acute Coronary Syndromes: a look into the eye of the perfect (cytokine) storm.Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies.Fluid challenge predicts clinical worsening in pulmonary arterial hypertension.The adipokine apelin-13 induces expression of prothrombotic tissue factor.C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes.Rapid ultrasound score as an indicator of atherosclerosis' clinical manifestations in a population of hypertensives: the interrelationship between flow-mediated dilatation of brachial artery, carotid intima thickness, renal resistive index and retinRole of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injuryDifferential enhancement of postischemic segmental systolic thickening by diltiazemPatients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable PlaqueUsefulness of late coronary thrombolysis (recombinant tissue-type plasminogen activator) in preserving left ventricular function in acute myocardial infarctionEffects of tissue factor induced by oxygen free radicals on coronary flow during reperfusionEffects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic functionLocal effect of serotonin released during coronary angioplasty
P50
Q33161216-358AFCCA-1289-4693-BE5D-30F1A30EA3D2Q33354913-2AE13D06-CCDC-4B0B-A61A-9AA8CAFCD6B5Q36050521-27701F7C-4A1B-4BD8-8CD1-019BAC0917D4Q37135235-802FC64F-15F4-4A4F-B436-55DA1D7232ACQ37340306-91B62A4B-AFED-48E1-A375-7C662E870FD2Q37631459-88A50B9C-A332-4A13-8CFD-2E3F6A41F354Q37862123-D86FEA6A-17C4-4961-AC1C-69E17F5CD0F8Q38073155-C3BCB3C6-ADE4-4077-B251-44B995E35DF3Q38174800-B1EA15C9-6658-49C6-993A-DD27FF40EC6FQ38231099-C1DA114F-D56F-4B03-ABE8-A024C7D836DEQ38286288-9BF53D83-F7D1-492A-AAE0-B04938E4CC56Q38593278-5DFF96DD-1DD4-44BA-ACF0-3B1AC13E5260Q39243150-CE4B2EE1-A6B2-4EA8-BA69-2302223D707DQ41355131-29240859-14CB-4CAC-8EFE-0F819AA75242Q43739933-B66D1237-F998-4ABD-B44F-766869453C59Q44632355-5795D6BE-D386-4399-912E-4B1FD57DC0EBQ44917953-14EAD418-4C65-4BD2-8BD6-056AF3BBD232Q45989586-CAAC802C-D06E-476B-9B54-42CB975499FDQ46951554-8FDFFC2C-958D-4164-AEEB-2A7A32F59140Q47398983-4A3D7123-7FD3-4ACF-B9BF-102A9E6FBC36Q47400959-3560B62B-2BA5-4717-AED2-5474B04DC140Q47971926-5D9CAF76-990D-4D74-B4D4-BE07FC2A0DCAQ51136795-A3BACAD6-AFB8-48BC-8570-004B2D3A97CDQ51483786-E26B812C-BE4A-47C1-8192-3FD1D75650A8Q51537695-A57CDFCC-6D48-4086-832C-D4C1DB7B3FD5Q51600530-0A28B02D-919B-4F77-B644-7B69EF003A17Q51637678-8E0F8D72-DFDA-408D-9A15-8679FDDB1218Q51706622-856F0B36-2325-4661-A22D-90FF15A0FC29Q51737068-71D51433-9CD1-4186-BA3B-CFAA405739C3Q52646309-DD608B5C-8B84-466F-B593-DFA84DBAC4E7Q54189187-A2C7CDEF-8A9B-475B-A95A-3475E8553C05Q54357051-664D02AC-0BAD-4A6B-96E6-E27807AA3741Q54432323-A3C5F108-6906-41BF-8341-DBB0A1A6CC48Q57636027-6123936E-0ADA-4C01-8DF5-AC05510B87C1Q57636043-546A4840-856D-46DD-9F68-79D233B107D9Q61848544-CFB00F6E-7F2C-493E-B222-01316292B8A1Q68366678-07E6E72F-17A2-41D8-BD0A-2A7A836BB9FBQ70908026-6953885E-748D-4A9B-BC7D-CB33B04D2D46Q71076713-4E730D49-4865-4A00-819F-C6472564FA93Q72088366-CD6B73AE-4B2C-4A95-93E9-B3EA72586B5C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paolo Golino
@ast
Paolo Golino
@en
Paolo Golino
@es
Paolo Golino
@nl
type
label
Paolo Golino
@ast
Paolo Golino
@en
Paolo Golino
@es
Paolo Golino
@nl
prefLabel
Paolo Golino
@ast
Paolo Golino
@en
Paolo Golino
@es
Paolo Golino
@nl
P106
P1153
7006544540
P31
P496
0000-0002-3590-6983